AIDS Healthcare Foundation (AHF) applauds the U.S. Federal Trade Commission (FTC) for taking decisive action against pharmacy benefit managers (PBMs) that drive up costs for insulin, a product never ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

Jørgensen, however, is set to argue that Novo is not the problem, but drug middlemen, known as pharmacy benefit managers ...

PBMs are companies that serve as middlemen to ... the state sued the drug manufacturers Novo Nordisk, Sanofi and Eli Lilly, ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of ...

The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

The agency plans to argue that the company illegally penalizes customers that try to use rival payment processors.

The disparity between patients with public and private insurance may play into a further inequality of prenatal diagnoses of ...